Prepping Gay Men for PrEP
Researchers have confirmed the effectiveness of pre-exposure prophylaxis, a technique in which people who are HIV-negative use antiretroviral drugs to protect themselves from infection. But the World Health Organization and others must ensure that PrEP is available to those who need it most: gay men in the developing world.
LONDON – In October, two groups researching the effectiveness of a potential breakthrough drug in the fight against HIV did something unusual. They announced that the therapy they were testing, an antiretroviral drug called Truvada, had proved effective enough to end the randomized phases of the trials, and that they were offering the pill to all of the studies’ participants.